NJ BIO
Suven Pharma sets sights on M&As to scale up tech expertise & order bookSuven Pharmaceuticals, backed by Advent International, is eyeing further mergers and acquisitions to bolster its capabilities and order boo...10 Dec, 2024, 11.58 PM IST
Suven Pharma to acquire 56 pc stake in US-based firm for USD 64.4 mnSuven Pharmaceuticals will acquire a 56% stake in US-based NJ Bio Inc for USD 64.4 million. This acquisition aligns with Suven's goal of be...07 Dec, 2024, 04.34 PM IST
Load More